Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01426620 · ClinicalTrials.gov registry record · Phase 2
Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer
A Phase 2 study, sponsored by University of Louisville.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT01426620 is a Phase 2 study that was terminated before completion, run by University of Louisville. The registered enrollment target is 4 participants.
The verdict
NCT01426620, a Phase 2 study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
This phase II trial will evaluate phyto-therapy's, in the form of blueberry powder, synergistic effect on second-line therapy for non-small cell lung cancer (NSCLC). The proposition is that the addition of blueberry polyphenolics to routine docetaxel therapy will have a significant, positive effect in the response rate and overall survival.
Interventions
- DIETARY_SUPPLEMENT Blueberry powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01426620
The ClinicalTrials.gov registry entry for NCT01426620 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blueberry powder is the first listed.
NCT01426620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01426620 about?
NCT01426620 is a clinical study titled "Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer". This phase II trial will evaluate phyto-therapy's, in the form of blueberry powder, synergistic effect on second-line therapy for non-small cell lung cancer (NSCLC). The proposition is that the addition of blueberry polyphenolics to routine docetaxel therapy will have a significant, positive effect ...
What is the current status of trial NCT01426620?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2011-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01426620?
The interventions under investigation include: Blueberry powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01426620?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.